Home › NCT04797039

MRI-Guided Cryoablation for Focal Native Prostate Cancer

Who can join

Ages 30 to 100 · Men

Inclusion Criteria:

* Patients with "biopsy proven" Gleason7 prostate cancer referred to Urology and/or Interventional Radiology for treatment
* Surgery and/or Radiation is not a desirable alternative therapy at the time of enrollment
* Tumor size is \< 2 cm at its largest diameter
* Tumor does not encompass the rectal wall or external urethral sphincter
* Patient is able to undergo MRI

Exclusion Criteria:

•

About the study

The purpose of this research is to collect data about the MRI cryoablation procedure your doctor(s) would normally perform in order to treat the participants focal prostate cancer and to evaluate the participants condition after the participants treatment is performed.

Participants have been asked to take part in this research because the participants have been diagnosed with prostate cancer and scheduled to have an ablation procedure.

What is being tested

• MR guided cryoablation (procedure)

Sponsor: Mayo Clinic · Participants: 100 · Started: Dec 1, 2020

Contact the study team

• Desirae Howe-Clayton · Phone: 507-255-0111

Official record on ClinicalTrials.gov — NCT04797039

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.